A commonly prescribed antibiotic used to treat skin conditions and infections may offer protection against the development of ...

Medication is the default schizophrenia treatment; however, it may not address key symptoms like social and cognitive deficits. Group therapy may be a new, promising intervention.

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb, combines ...

Schizophrenia is a complex mental health condition characterized by a disruption in a person’s thoughts, perceptions, emotions, and behavior. It can be a debilitating condition, but with proper ...

Cobenfy, the first new schizophrenia drug in 50 years, offers early insights that could pave the way for more personalized psychosis treatment.

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies showed ...

They are more likely to die from disease. They are more likely to die from violence. They are more likely to die as they age. And they don’t live nearly as long. The life expectancy of people with ...

This post was written by Eugene Rubin, MD, Ph.D., and Charles Zorumski, MD. Schizophrenia is a severe, chronic disorder characterized by "positive" symptoms such as hallucinations, delusions (fixed, ...

Schizoaffective disorder and schizophrenia are separate mental disorders. Learn about both, including symptoms, risk factors, and treatment.

Panelists discuss how negative symptoms like lack of motivation, social withdrawal, and impaired expression significantly impact patients’ ability to maintain relationships and employment, ...

A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Md. automation The U.S. Food and Drug Administration (FDA) on Thursday approved the first ...